{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:08:38Z","timestamp":1770232118258,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,2,5]],"date-time":"2012-02-05T00:00:00Z","timestamp":1328400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11033-012-1517-z","type":"journal-article","created":{"date-parts":[[2012,2,4]],"date-time":"2012-02-04T16:16:26Z","timestamp":1328372186000},"page":"6907-6914","source":"Crossref","is-referenced-by-count":25,"title":["IL-1\u03b2 (\u2212511T\/C) gene polymorphism not IL-1\u03b2 (+3953T\/C) and LT-\u03b1 (+252A\/G) gene variants confers susceptibility to visceral leishmaniasis"],"prefix":"10.1007","volume":"39","author":[{"given":"Ali","family":"Moravej","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoochehr","family":"Rasouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Asaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Kiany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohrab","family":"Najafipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Koohpayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,5]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","volume":"354","author":"BL Herwaldt","year":"1999","unstructured":"Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191\u20131199","journal-title":"Lancet"},{"key":"1517_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305\u2013318","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"1517_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","volume":"22","author":"RD Pearson","year":"1996","unstructured":"Pearson RD, Sousa AQ (1996) Clinical spectrum of Leishmaniasis. Clin Infect Dis 22:1\u201313","journal-title":"Clin Infect Dis"},{"key":"1517_CR4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/506624","volume":"194","author":"NA Ansari","year":"2006","unstructured":"Ansari NA, Ramesh V, Salotra P (2006) Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 194:958\u2013965","journal-title":"J Infect Dis"},{"key":"1517_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cyto.a.20256","volume":"69","author":"KM Kurkjian","year":"2006","unstructured":"Kurkjian KM, Mahmutovic AJ, Kellar KL, Haque R, Bern C, Secor WE (2006) Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis. Cytometry 69:353\u2013358","journal-title":"Cytometry"},{"key":"1517_CR6","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","volume":"166","author":"P Wilhelm","year":"2001","unstructured":"Wilhelm P, Ritter U, Labbow S et al (2001) Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF. J Immunol 166:4012\u20134019","journal-title":"J Immunol"},{"key":"1517_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/intimm\/dxq006","volume":"22","author":"E Voronov","year":"2010","unstructured":"Voronov E, Dotan S, Gayvoronsky L et al (2010) IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB\/c mice. Int Immunol 22:245\u2013257","journal-title":"Int Immunol"},{"key":"1517_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.vetimm.2006.10.003","volume":"115","author":"VM Lima de","year":"2007","unstructured":"de Lima VM, Peiro JR, de Oliveira Vasconcelos R (2007) IL-6 and TNF-alpha production during active canine visceral leishmaniasis. Vet Immunol Immunopathol 115:189\u2013193","journal-title":"Vet Immunol Immunopathol"},{"key":"1517_CR9","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.4049\/jimmunol.179.8.5358","volume":"179","author":"G Xu","year":"2007","unstructured":"Xu G, Liu D, Fan Y et al (2007) Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice. J Immunol 179:5358\u20135366","journal-title":"J Immunol"},{"key":"1517_CR10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)63262-2","volume":"165","author":"CR Engwerda","year":"2004","unstructured":"Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, Kaye PM (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165:2123\u20132133","journal-title":"Am J Pathol"},{"key":"1517_CR11","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","volume":"68","author":"HW Murray","year":"2000","unstructured":"Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW (2000) Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immunol 68:6289\u20136293","journal-title":"Infect Immunol"},{"key":"1517_CR12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487\u2013501","journal-title":"Cell"},{"key":"1517_CR13","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","volume":"145","author":"FY Liew","year":"1990","unstructured":"Liew FY, Li Y, Millott S (1990) Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145:4306\u20134310","journal-title":"J Immunol"},{"key":"1517_CR14","first-page":"556","volume":"71","author":"FY Liew","year":"1990","unstructured":"Liew FY, Li Y, Millott S (1990) Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from l-arginine. Immunology 71:556\u2013559","journal-title":"Immunology"},{"key":"1517_CR15","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.4049\/jimmunol.162.10.5965","volume":"162","author":"CA Cuff","year":"1999","unstructured":"Cuff CA, Sacca R, Ruddle NH (1999) Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol 162:5965\u20135972","journal-title":"J Immunol"},{"key":"1517_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.160.1.485","volume":"160","author":"R Sacca","year":"1998","unstructured":"Sacca R, Cuff CA, Lesslauer W, Ruddle NH (1998) Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. J Immunol 160:485\u2013491","journal-title":"J Immunol"},{"key":"1517_CR17","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095\u20132147","journal-title":"Blood"},{"key":"1517_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1359-6101(98)00018-5","volume":"9","author":"PE Auron","year":"1998","unstructured":"Auron PE (1998) The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev 9:221\u2013237","journal-title":"Cytokine Growth Factor Rev"},{"key":"1517_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20030159","volume":"198","author":"E Stebut Von","year":"2003","unstructured":"Von Stebut E, Ehrchen JM, Belkaid Y et al (2003) Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB\/c mice. J Exp Med 198:191\u2013199","journal-title":"J Exp Med"},{"key":"1517_CR20","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/sj.jid.5700309","volume":"126","author":"SL Kostka","year":"2006","unstructured":"Kostka SL, Knop J, Konur A, Udey MC, von Stebut E (2006) Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections. J Invest Dermatol 126:1582\u20131589","journal-title":"J Invest Dermatol"},{"key":"1517_CR21","first-page":"131","volume":"5","author":"M Rasouli","year":"2008","unstructured":"Rasouli M, Kiany S, Behbin M (2008) Interleukin-10 gene polymorphisms and susceptibility to brucellosis in Iranian patients. Iran J Immunol 5:131\u2013135","journal-title":"Iran J Immunol"},{"key":"1517_CR22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2011.02.011","volume":"54","author":"M Rasouli","year":"2011","unstructured":"Rasouli M, Kalani M, Moravej A, Kiany S (2011) Interleukin-18 single nucleotide polymorphisms contribute to the susceptibility to brucellosis in Iranian patients. Cytokine 54:272\u2013276","journal-title":"Cytokine"},{"key":"1517_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cyto.2007.05.003","volume":"38","author":"M Rasouli","year":"2007","unstructured":"Rasouli M, Kiany S (2007) Association of interferon-gamma and interleukin-4 gene polymorphisms with susceptibility to brucellosis in Iranian patients. Cytokine 38:49\u201353","journal-title":"Cytokine"},{"key":"1517_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1054\/tuld.1998.0009","volume":"79","author":"R Bellamy","year":"1998","unstructured":"Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV (1998) Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 79:83\u201389","journal-title":"Tuber Lung Dis"},{"key":"1517_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cyto.2006.07.016","volume":"35","author":"E Kamali-Sarvestani","year":"2006","unstructured":"Kamali-Sarvestani E, Rasouli M, Mortazavi H, Gharesi-Fard B (2006) Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients. Cytokine 35:159\u2013165","journal-title":"Cytokine"},{"issue":"3","key":"1517_CR26","first-page":"117","volume":"56","author":"D Trajkov","year":"2009","unstructured":"Trajkov D, Trajchevska M, Arsov T et al (2009) Association of 22 cytokine gene polymorphisms with tuberculosis in Macedonians. Indian J Tuberculosis 56(3):117\u2013131","journal-title":"Indian J Tuberculosis"},{"key":"1517_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1084\/jem.173.1.209","volume":"173","author":"G Messer","year":"1991","unstructured":"Messer G, Spengler U, Jung MC et al (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173:209\u2013219","journal-title":"J Exp Med"},{"key":"1517_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GIM.0b013e3181632713","volume":"10","author":"V Asensi","year":"2008","unstructured":"Asensi V, Rego C, Montes AH et al (2008) IL-1beta (+3954C\/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome. Genet Med 10:215\u2013223","journal-title":"Genet Med"},{"key":"1517_CR29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.20299","volume":"27","author":"M Chakravorty","year":"2006","unstructured":"Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S (2006) Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 27:411\u2013419","journal-title":"Hum Mutat"},{"key":"1517_CR30","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00003246-199907000-00024","volume":"27","author":"XM Fang","year":"1999","unstructured":"Fang XM, Schroder S, Hoeft A, Stuber F (1999) Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 27:1330\u20131334","journal-title":"Crit Care Med"},{"key":"1517_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.ejhg.5201084","volume":"12","author":"AJ Walley","year":"2004","unstructured":"Walley AJ, Aucan C, Kwiatkowski D, Hill AV (2004) Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet 12:132\u2013138","journal-title":"Eur J Hum Genet"},{"key":"1517_CR32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1902\/jop.2000.71.2.156","volume":"71","author":"MJ McDevitt","year":"2000","unstructured":"McDevitt MJ, Wang HY, Knobelman C et al (2000) Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 71:156\u2013163","journal-title":"J Periodontol"},{"key":"1517_CR33","first-page":"266","volume":"12","author":"M Rasouli","year":"2010","unstructured":"Rasouli M, Kiany S, Moravej A, Kalani M (2010) Interleukin-12 and Tumor necrosis factor-\u0392 Gene polymorphisms as genetic susceptibility factors for Brucellosis in Iranian patients. Iran Red Crescent Med J 12:266\u2013271","journal-title":"Iran Red Crescent Med J"},{"key":"1517_CR34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","volume":"22","author":"F Pociot","year":"1992","unstructured":"Pociot F, M\u00f8lvig J, Wogensen L, Worsaae H, Nerup J (1992) A TaqI polymorphism in the human interleukin- 1beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22:396\u2013402","journal-title":"Eur J Clin Invest"},{"key":"1517_CR35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/hmg\/1.6.450","volume":"1","author":"FS Giovine di","year":"1992","unstructured":"di Giovine FS, Takhsh E, Blakemore AI, Duff GW (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1:450","journal-title":"Hum Mol Genet"},{"key":"1517_CR36","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1097\/00003246-199310001-00002","volume":"21","author":"B Beutler","year":"1993","unstructured":"Beutler B, Grau GE (1993) Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 21:S423\u2013S435","journal-title":"Crit Care Med"},{"key":"1517_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","volume":"10","author":"P Vassalli","year":"1992","unstructured":"Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411\u2013452","journal-title":"Annu Rev Immunol"},{"key":"1517_CR38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830200528","volume":"20","author":"C Bogdan","year":"1990","unstructured":"Bogdan C, Moll H, Solbach W, Rollinghoff M (1990) Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 20:1131\u20131135","journal-title":"Eur J Immunol"},{"key":"1517_CR39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/eji.1830230135","volume":"23","author":"F Pociot","year":"1993","unstructured":"Pociot F, Briant L, Jongeneel CV et al (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224\u2013231","journal-title":"Eur J Immunol"},{"key":"1517_CR40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2334-10-165","volume":"10","author":"S Sharma","year":"2010","unstructured":"Sharma S, Rathored J, Ghosh B, Sharma SK (2010) Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis 10:165","journal-title":"BMC Infect Dis"},{"key":"1517_CR41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1572-0241.2005.40806.x","volume":"100","author":"C Li","year":"2005","unstructured":"Li C, Xia B, Yang Y, Li J, Xia HH (2005) TNF gene polymorphisms and Helicobacter Pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 100:290\u2013294","journal-title":"Am J Gastroenterol"},{"key":"1517_CR42","first-page":"96","volume":"7","author":"S Farshad","year":"2010","unstructured":"Farshad S, Rasouli M, Jamshidzadeh A et al (2010) IL-1\u03b2 (+3953 C\/T) and IL-8 (\u2212251 A\/T) gene polymorphisms in H. pylori mediated gastric disorders. Iran J Immunol 7:96\u2013108","journal-title":"Iran J Immunol"},{"issue":"3","key":"1517_CR43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GIM.0b013e3181632713","volume":"10","author":"V Asensi","year":"2008","unstructured":"Asensi V, Rego C, Montes AH et al (2008) IL-1beta (+3954C\/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome. Genet Med 10(3):215\u2013223","journal-title":"Genet Med"},{"issue":"5","key":"1517_CR44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.20299","volume":"27","author":"M Chakravorty","year":"2006","unstructured":"Chakravorty M, Ghosh A, Choudhury A, Santra A, Hembrum J, Roychoudhury S (2006) Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 27(5):411\u2013419","journal-title":"Hum Mutat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1517-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T09:18:50Z","timestamp":1686734330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1517-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,5]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1517-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,5]]}}}